We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




Noninvasive Laser Therapy for Stroke Treatment Could Help Avoid Surgical Removal of Blood Clot

By HospiMedica International staff writers
Posted on 20 Jun 2024

Individuals suffering from stroke currently have limited treatment options, generally involving a combination of intravenous thrombolysis and endovascular thrombectomy—methods involving the injection of clot-busting drugs and the mechanical removal of blood clots. More...

However, these treatments are only effective within a specific timeframe and are suitable for only a subset of patients. Now, new research has revealed the potential for non-invasive light treatment for stroke utilizing lasers.

The approach targets endothelial cells, which line the blood vessels and play a pivotal role in the onset of stroke due to their dysfunction, marked by reduced production of nitric oxide (NO). NO is essential for keeping blood vessels open to ensure free blood flow. Building on prior findings that laser therapy can enhance NO production in these cells, researchers from Massachusetts General Hospital (Boston, MA, USA) explored the impact of laser therapy in a mouse stroke model.

Their findings indicate that applying low-power, invisible laser light to the head can significantly enhance brain blood flow and reduce stroke-related damage. The mechanism appears to involve laser treatment boosting NO production, which in turn improves blood vessel function in the brain. Given the established safety record of laser treatments for other medical conditions, there is optimism about the feasibility of testing this method in human trials soon. Additionally, laser therapy holds promise for treating a variety of other cardiovascular diseases linked to NO deficiencies.

“Unlike other approaches using chemicals, which can be toxic to our bodies, laser light is a physical parameter. It does not stay in the body after the therapy and will have little chance of causing side effects,” said co-senior author Satoshi Kashiwagi, MD, PhD, an investigator in the Department of Radiology at Massachusetts General Hospital. “We discovered a new way to effectively treat stroke using laser light, a modality that is already widely used in the clinic for procedures such as Lasik eye surgery and tattoo removal, and has a well-known safety profile. Thus, we expect that we could advance this technology to clinical trials relatively soon. Such technology has the potential to replace the current standard therapy using chemicals, which may cause side effects.”

Related Links:
Massachusetts General Hospital


Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Gold Member
12-Channel ECG
CM1200B
New
Half Apron
Demi
New
Mammography System (Analog)
MAM VENUS
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: A research collaboration aims to further advance findings in human genomics research in cardiovascular diseases (Photo courtesy of 123RF)

Bayer and Broad Institute Extend Research Collaboration to Develop New Cardiovascular Therapies

A research collaboration will focus on the joint discovery of novel therapeutic approaches based on findings in human genomics research related to cardiovascular diseases. Bayer (Berlin, Germany) and... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.